Unlocking the Future: Bioasis Technologies Inc. Sends Out Must-Read Circular for Annual Meeting of Securityholders
Bioasis Technologies Inc. Mails Management Information Circular for Annual and… New Haven, Conn., Jan. 11, 2023 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (OTCQB:BIOAF; TSX.V:BTI) is a multi-asset rare and orphan disease biopharmaceutical company focusing on developing clinical stage programs based on epidermal growth factor and a differentiated, proprietary xB3™ platform for delivering therapeutics across the…